{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:31:56Z","timestamp":1761183116541,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jiac.2021.11.018","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T22:34:56Z","timestamp":1637793296000},"page":"329-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Recovery from severe persistent COVID-19 without evidence of an anti-SARS-CoV-2 antibody response in a man with mantle cell lymphoma treated with rituximab"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-4520","authenticated-orcid":false,"given":"Hiroshi","family":"Horiuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0079-2883","authenticated-orcid":false,"given":"Kazuhito","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuo","family":"Tachikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.jiac.2021.11.018_bib1","first-page":"11926","article-title":"Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review","volume":"24","author":"Kim","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"27","key":"10.1016\/j.jiac.2021.11.018_bib2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jiac.2021.11.018_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/jiaa666","article-title":"Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient","volume":"223","author":"Baang","year":"2021","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.jiac.2021.11.018_bib4","doi-asserted-by":"crossref","first-page":"102871","DOI":"10.1016\/j.transci.2020.102871","article-title":"Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma","volume":"59","author":"Karata\u015f","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"10.1016\/j.jiac.2021.11.018_bib5","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1111\/bjh.16935","article-title":"Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience","volume":"190","author":"Shah","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jiac.2021.11.018_bib6","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3389\/fonc.2020.01578","article-title":"Prolonged course of COVID-19-associated pneumonia in a B-cell depleted patient After rituximab","volume":"10","author":"Kos","year":"2020","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.jiac.2021.11.018_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41408-021-00546-9","article-title":"Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab","volume":"11","author":"Cattaneo","year":"2021","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.jiac.2021.11.018_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjh.16896","article-title":"Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature","volume":"190","author":"Tepasse","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jiac.2021.11.018_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13027-021-00376-1","article-title":"Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab","volume":"16","author":"Marcacci","year":"2021","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"10.1016\/j.jiac.2021.11.018_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clml.2020.06.012","article-title":"Successful use of COVID-19 convalescent plasma in a patient recently treated for follicular lymphoma","volume":"21","author":"Wright","year":"2021","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"issue":"1","key":"10.1016\/j.jiac.2021.11.018_bib11","doi-asserted-by":"crossref","DOI":"10.3201\/2701.203772","article-title":"Cellular immunity in COVID-19 convalescents with PCR-confirmed infection but with undetectable SARS-CoV-2-specific IgG","volume":"27","author":"Schwarzkopf","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.jiac.2021.11.018_bib12","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1016\/S2352-3026(20)30251-9","article-title":"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study","volume":"7","author":"Passamonti","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jiac.2021.11.018_bib13","article-title":"T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies","author":"Marasco","year":"2021","journal-title":"Br J Haematol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21003299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21003299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:03:57Z","timestamp":1761159837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21003299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1341321X21003299"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.11.018","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recovery from severe persistent COVID-19 without evidence of an anti-SARS-CoV-2 antibody response in a man with mantle cell lymphoma treated with rituximab","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}